← All stocks

PULSE BIOSCIENCES, INC.

PLSE Net buying
CIK 0001625101 #1646 in the set updated 17 Sep 2026
Bought (120 mo)
$213.88M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.71M
$0.00 on a plan · $6.36M straight out of an exercise
Sold at will
$1.36M
3 of 23 sales
Net
+$206.17M
+$212.52M against sales at will

By person

11 insiders · 211 transactions
1.0×

Paul A. LaViolette holds only 1.0 times base salary in stock. $749.25K of shares against $708.52K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul A. LaViolette last reported holding, valued at $49.95, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DUGGAN ROBERT W
Director
$210.07M (83)
+$210.07M
48,991,641
68.69%
$2.45B
+2,811%
Danahy Kevin Patrick
Chief Commercial Officer
$50.11K (4)
$3.39M (10) scheduled
−$3.34M
43,298
0.0607%
$2.16M
+40.8%
Zanganeh Mahkam
Director
$2.96M (20)
+$2.96M
969,043
1.36%
$48.40M
+133.0%
UECKER DARRIN
Chief Technology Officer
$2.34M (7) scheduled
−$2.34M
284,406
0.3988%
$14.21M
+2,531%
Barrett Burke Thomas
Former President and CEO
$85.60K (1)
$871.00K (1)
−$785.40K
63,172
0.0886%
$3.16M
−37.5%
Thaure Thierry B.
Director
$581.32K (3) scheduled
−$581.32K
0
0.0000%
$0.00
Greenberg Robert J.
Director
$528.11K (2) scheduled
−$528.11K
0
0.0000%
$0.00
LAVIOLETTE PAUL A
Chief Executive Officer
$295.35K (1)
+$295.35K
15,000
0.0210%
$749.25K
Levinson Mitchell E.
Chief Strategy Officer
$222.17K (19)
+$222.17K
106,313
0.1491%
$5.31M
+840.7%
Teplitsky Liane Rae
Chief Operating Officer
$199.94K (4)
+$199.94K
4,095
0.0057%
$204.55K
Ebbers Ed
EVP & GM, Dermatology
39,300
0.0551%
$1.96M
−9.6%
Insider
Date
Role
Action
Shares
Price
Amount
Danahy Kevin Patrick
18 Feb 2026
Chief Commercial Officer
Sold after exercise
5,000
$23.64
$118.20K
Danahy Kevin Patrick
17 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.63
$472.60K
Danahy Kevin Patrick
13 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.53
$470.60K
Danahy Kevin Patrick
12 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.37
$467.40K
Danahy Kevin Patrick
11 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$25.20
$504.00K
Danahy Kevin Patrick
10 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.52
$470.40K
Danahy Kevin Patrick
9 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$21.45
$429.00K
Danahy Kevin Patrick
2 Oct 2025
Chief Commercial Officer
Sold after exercise
4,600
$18.53
$85.24K
Danahy Kevin Patrick
19 Sep 2025
Chief Commercial Officer
Sold after exercise
400
$18.48
$7.39K
Danahy Kevin Patrick
18 Sep 2025
Chief Commercial Officer
Sold after exercise
20,000
$18.49
$369.80K
UECKER DARRIN
17 Sep 2025
Chief Technology Officer
Sold after exercise
20,000
$16.21
$324.20K
UECKER DARRIN
16 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$16.28
$407.00K
UECKER DARRIN
15 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$15.77
$394.25K
UECKER DARRIN
12 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$14.32
$358.00K
UECKER DARRIN
11 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$14.78
$369.50K
Thaure Thierry B.
12 May 2017
Director
Sold after exercise
5,000
$24.90
$124.50K
Thaure Thierry B.
12 May 2017
Director
Sold after exercise
5,000
$23.90
$119.50K
Greenberg Robert J.
10 May 2017
Director
Sold after exercise
2,820
$21.87
$61.66K
Greenberg Robert J.
10 May 2017
Director
Sold after exercise
22,180
$21.03
$466.45K
Thaure Thierry B.
8 May 2017
Director
Sold after exercise
15,000
$22.49
$337.32K

What was left out

Form 4 filings counted 196
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 20
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 29,589,146
History held since 16 Nov 2016